other_material
confidence high
sentiment neutral
materiality 0.75
Marker Therapeutics shareholders approve increase in authorized shares from 30M to 130M
Marker Therapeutics, Inc.
- Shareholders approved Charter Amendment to increase authorized common stock from 30M to 130M shares (10.9M for, 1.4M against).
- Proposal to revise voting threshold for share changes failed; broker non-votes prevented passage.
- All five director nominees re-elected; advisory vote on executive compensation passed.
- Ratification of CBIZ CPAs as independent auditor for fiscal 2026 approved by shareholders.